1. Clinical and therapeutic implications of sex steroid hormone receptor status in urothelial bladder cancer
   P Venugopal et al, 2020, Indian Journal of Urology CrossRef
2. The androgen receptor in bladder cancer
   Jinbo Chen et al, 2023, Nature Reviews Urology CrossRef
3. Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer
   Kassim Kourbanhoussen et al, 2021, European Urology Focus CrossRef
4. Androgen receptor variant 12 promotes migration and invasion by regulating MYLK in gastric cancer
   Nan Xia et al, 2019, The Journal of Pathology CrossRef
5. Role of the Androgen Receptor in Gender-Related Cancers
   Emilia Sabbatino et al, 2023, Endocrines CrossRef
6. Role of the androgen receptor in urothelial cancer
   Satoshi Inoue et al, 2018, Molecular and Cellular Endocrinology CrossRef
7. Roles of Androgen Receptor Signaling in Urothelial Carcinoma
   Debasish Sundi et al, 2024, Cancers CrossRef
8. Comprehensive analysis of microRNA‐messenger RNA regulatory network in gemcitabine‐resistant bladder cancer cells
   Su Zhang et al, 2019, Journal of Cellular Biochemistry CrossRef
9. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer
   Mohammad Amin Elahi Najafi et al, 2023, International Journal of Molecular Sciences CrossRef
10. Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma
    Remi Adelaiye-Ogala et al, 2018, Cancer Research CrossRef
11. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer
    Yongjun Quan et al, 2019, Biomedicine & Pharmacotherapy CrossRef
12. Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy
    Hiroki Ide et al, 2021, Cells CrossRef
13. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells
    Kyoung-Hwa Lee et al, 2020, International Journal of Molecular Sciences CrossRef
14. Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies
    Massimiliano Creta et al, 2021, Diagnostics CrossRef
15. Androgen Receptor Transcriptionally Inhibits Programmed Death Ligand-1 Expression and Influences Immune Escape in Bladder Cancer
    Anran Sun et al, 2023, Laboratory Investigation CrossRef
16. Crosstalk of disulfidptosis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in bladder cancer based on a machine learning survival framework
    Songyun Zhao et al, 2023, Frontiers in Endocrinology CrossRef
17. Androgen Receptor Signaling in Bladder Cancer
    Peng Li et al, 2017, Cancers CrossRef
18. Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder
    Ashish Tyagi et al, 2019, Urologic Oncology: Seminars and Original Investigations CrossRef
19. Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer
    Yuki Teramoto et al, 2021, International Journal of Molecular Sciences CrossRef
20. Influence of gender on the pathophysiology and treatment of urological malignancies
    Reza Sari Motlagh et al, 2023, Principles of Gender-Specific Medicine CrossRef
21. Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer
    Javier Leo et al, 2023, Endocrinology CrossRef
22. Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancer
    Antonia K. Roseweir et al, 2017, Oncotarget CrossRef